Introduction
In most parts of the world, Candida albicans is still the predominant species isolated from blood in non-neutropenic patients, but its recovery has been reported to be declining in many institutes [1] . In some studies, the isolation of non-C. albicans Candida species even surpasses C. albicans , reaching proportions as high as 60 -70% [2] of the cases. A few previous studies had sought to identify specifi c risk factors for non-C. albicans candidemia, but yielded different results from one another. The objective of this study was to explore the epidemiology of nosocomial candidemia in non-candidemia (before or within 48 h of hospital admission) [3] , and those without complete case fi les were excluded. Records indicating multiple positive blood cultures from the same patient were considered as part of the same episode. Medical records were retrieved and data were collected relative to the timing of candidemia, demographic data, underlying illnesses, and potential risk factors for candidemia within 30 days prior to positive blood cultures.
Statistical analysis
Statistical analyses were performed using STATA 9.2 (StataCorp, College Station, Texas). Signifi cance level was set at P Ͻ 0.05. To compare variables, the Fisher ' s exact, Pearson ' s chi-square test, the two-sided t test and the rank sum test were used as appropriate. Parameters related to non-C. albicans candidemia were analyzed by multivariate logistic regression.
Results

Incidence and pathogen
One hundred and two patients were included in the study. Six neutropenic patients with candidemia, 11 with health care associated candidemia, and 11 with incomplete case fi les were excluded. The average incidence rate during the study period was 0.26/10,000 patient-days. C. albicans was the most common pathogen (57.8%, 59/102), followed by C. tropicalis (12.8%, 13/102), C. parapsilosis (10.8%, 11/102), C. glabrata (10.8%, 11/102). Other less common species included C. guilliermondii , C. famata , C. krusei and C. rugosa . There was no apparent change in species distribution pattern over the study period (Fig. 1) .
Demographic features, underlying diseases and risk factors
There were 60 males and 42 females. The average age was 59.1 Ϯ 17.3 years . The median time from admission to the fi rst positive blood specimen was 28 days. Most of the patients were from surgical wards (53.9%, 55/102), 23 (22.5%) patients from medical wards, and 24 (23.5%) from ICU. Common underlying diseases and risk factors 30 days prior to the fi rst positive blood culture are listed in Table 1 .
C. albicans vs. non-C. albicans candidemia
Comparison of the features of C. albicans and non-C. albicans candidemia were listed in Table 1 . As regards to underlying diseases, chemotherapy was associated with non-C. albicans candidemia whereas high peripheral WBC count was related to C. albicans candidemia. Fluconazole use for longer than 1 week prior to candidemia was also signifi cantly associated with non-C. albicans candidemia. In a model of multivariate logistic regression, as listed in Table 2 , factors independently predicting non-C. albicans candidemia included head trauma (OR, 5.34; 95% CI, 1.18 -24.17; P ϭ 0.029) and previous bacterial sepsis (OR, 3.58; 95% CI, 1.17 -10.98; P ϭ 0.026). Factors that independently predicted C. albicans candidemia included tracheal intubation (OR, 0.26; 95% CI, 0.08 -0.92; P ϭ 0.037) and high peripheral WBC count (OR, 0.84; 95% CI, 0.74 -0.95; P ϭ 0.006).
Discussion
The distribution of non-C. albicans Candida species in non-neutropenic patients varies greatly [4] . In our study, the most common non-C. albicans Candida species was C. tropicalis , followed by equal numbers of cases involving C. parapsilosis and C. glabrata . While our species distribution pattern is different from that reported in western countries as we observed fewer isolates of C. glabrata , C. krusei , and more caused by C. tropicalis , it is consistent with other studies from Asia. In the global surveillance from 1992 -2001 reported by Pfaller et al ., 14 of the 28 bloodstream isolates from China were C. albicans (50%), six were C. tropicalis (21.4%), six were C. glabrata (21.4%), one was C. parapsilosis (3.6%), and C. krusei was not recovered [5] . Most of previous studies from Taiwan, including a large survey of 1,095 blood isolates by Chen et al . and 403 isolates by Wu et al . have suggested similar results to those found in our investigation. Specifi cally, C. tropicalis was the most common non-C. albicans Candida species, C. parapsilosis or C. glabrata was isolated second most b For 1.0 ϫ 10 9 /l WBC cells increment. Five patients not tested for whole blood count at the time of diagnosis were not included in the initial model, and 6 patients with previous chemotherapy were excluded during regression because all of them had non-C. albicans candidemia. Therefore the number of cases in the fi nal model was 91.
frequently and C. krusei was relatively rarely encountered [6, 7] . In studies from other parts of Asia (Singapore, Japan, Korea, Thailand and India), the isolation rates of C. glabrata and C. krusei were also consistently low [8 -14] .
There have been a number of comparative studies trying to identify risk factors favoring non-C. albicans Candida species candidemia [15,16 -20] . In our patients with C. albicans candidemia, peripheral WBC counts at the time of positive cultures were signifi cantly higher than those found with non-C. albicans candidemia. This is consistent with the fi nding by Chen et al ., although the underlying mechanism is not clear [16] . The association of bacterial sepsis with non-C. albicans candidemia had not been reported elsewhere. However, Chow et al . and Lin et al . both demonstrated that prolonged broad-spectrum antibiotic therapy, as would occur with bacterial infection, was correlated to non-C. albicans candidemia [17, 18] . It is unknown whether the disruption of the mucosal barrier by bacterial infection, or the changes in microbial fl ora caused by the antibiotics contributed to the occurrence of non-C. albicans candidemia. We have also found that head trauma was independently associated with non-C. albicans candidemia in non-neutropenic patients, and tracheal intubation with C. albicans candidemia in the same patient population. However, these two factors have not been reported in other studies, and the underlying mechanisms remain unclear.
Previous use of antifungal agents had been known to increase the risk of non-C. albicans candidemia [17, 19] . In our patients, there was a weak association between prior use of fl uconazole for longer than 7 days and non-C. albicans candidemia in univariate analysis, but they are not significantly correlated in multivariate logistic regression. The relatively low dosage of fl uconazole used in empirical therapy (100 -200 mg/d) might have obscured the correlation in our patients, in that Safdar et al . found [16, 17, 22] . The great inter-study variations with respect to risk factor differences might be the result of heterogeneity in pathogens and study populations and underscores the importance of local epidemiology studies on a district by district, even institution by institution basis.
